Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-059587
Filing Date
2026-05-20
Accepted
2026-05-20 16:52:21
Documents
62
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0291120-10q_biomxinc.htm   iXBRL 10-Q 668702
2 CERTIFICATION ea029112001ex31-1.htm EX-31.1 12607
3 CERTIFICATION ea029112001ex31-2.htm EX-31.2 12572
4 CERTIFICATION ea029112001ex32.htm EX-32 5852
  Complete submission text file 0001213900-26-059587.txt   4874231

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE phge-20260331.xsd EX-101.SCH 50543
6 XBRL CALCULATION FILE phge-20260331_cal.xml EX-101.CAL 37653
7 XBRL DEFINITION FILE phge-20260331_def.xml EX-101.DEF 224496
8 XBRL LABEL FILE phge-20260331_lab.xml EX-101.LAB 425680
9 XBRL PRESENTATION FILE phge-20260331_pre.xml EX-101.PRE 243354
66 EXTRACTED XBRL INSTANCE DOCUMENT ea0291120-10q_biomxinc_htm.xml XML 507101
Mailing Address 850 NEW BURTON ROAD SUITE 201 DOVER DE 19904
Business Address 850 NEW BURTON ROAD SUITE 201 DOVER DE 19904 972 545610935
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 261004793
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)